Go Ad-Free
    My Alerts
    Moneycontrol
    Moneycontrol PRO
    HomeNewsOpinionThe bad bank is a placebo; it will work with only limited efficacy

    The bad bank is a placebo; it will work with only limited efficacy

    The NARCL strategy resembles trying to use a band-aid to staunch a deep flesh wound; it may work for only a short period and is, at best, a sub-optimal locum for the actual procedure

    Rajrishi Singhal
    March 09, 2022 / 08:15 IST
    Representative image
    • PRO Panorama

      Moneycontrol Pro Panorama | Beyond Q2: Will India Inc's robust ROCE translate into capex?

      Nov 17, 2025 / 03:39 PM IST

      In November 17 edition of Moneycontrol Pro Panorama: Bihar's landslide verdict cements bullish case for India's politics, why glob...

      Read Now
    Unlock This Article

    Are you a PRO subscriber? Sign In

    What Do You Get

    • Ad free Experience

      Seamless navigation, faster responses.

    • Expert Perspective

      Explore 230+ exclusive editorials every month

    • +

      Uncover Insights from World-Renowned Experts and Journalists

    • Actionable Insights

      40+ weekly investment ideas + 3 to 4 daily technical calls

    • Virtual Events

      Exclusive Live Webinars for Expert Trading & Investment Strategies!

    • Newsletters

      Stay ahead with daily and weekly insights

    View Offers

    Unlock exclusive discounts